Nalbuphine Plus Caudal Bupivacaine in Hypospadius Repair

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

October 1, 2020

Conditions
Post Operative Pain
Interventions
DRUG

Nalbuphine

Children will be randomly assigned into 2 groups of 30 patients each. They will receive caudal anesthesia using bupivacaine 0.25% 1ml/kg plus 2 ml normal saline in the control group, bupivacaine 0.25% 1ml/kg plus nalbuphine 0.1 mg/kg in 2 ml solution in the nalbuphine group.

Trial Locations (1)

Unknown

Faculty of Medicine, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03476772 - Nalbuphine Plus Caudal Bupivacaine in Hypospadius Repair | Biotech Hunter | Biotech Hunter